A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

HCPro, a leading provider of healthcare compliance, coding, and revenue cycle education, today announced a strategic partnership with ZHealth Publishing, a recognized authority in physician-led ...

The drugs that keep rheumatoid arthritis in check may one day help people stop drinking. A new Scripps Research study shows that an anti-inflammatory molecule, already approved by the U.S. Food and ...

The UAB Division of Clinical Immunology and Rheumatology is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, and ...

Robert Kelly is managing director of XTS Energy LLC, and has more than three decades of experience as a business executive. He is a professor of economics and has raised more than $4.5 billion in ...

Clinical genetics involves the study, counselling and treatment of individuals and families with heritable disorders and disease predisposition. Diagnostic tools include standard ontologies for ...

Hasan, Leucht et al. undertook a drug repurposing trial evaluating the mineralocorticoid antagonist spironolactone as a treatment for cognitive impairment in people with schizophrenia. The primary ...

Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic instructions can produce weight loss and blood glucose control in murine models that lasts ...

Health news moves fast, with new studies, findings, and regulatory updates changing the landscape daily. Insights from advocates and celebrities can also impact the public awareness of certain health ...

Clinical Trials for Real-World Elderly Patients With Metastatic Soft-Tissue Sarcomas: The Importance of Study Design and Patient-Reported Outcomes ...

The Medical News Today news team reports on emerging science, cutting-edge research, new treatments, and trending topics in health and medicine. All articles are written by our network of editors and ...

Prior authorization remains a major barrier to biologic access in AD. Dr Chuck Vega covers denial rates, appeal outcomes, and the clinical data that make the fight worthwhile.